Amylyx Pharmaceuticalsの空売り状況は、投資家がAmylyx Pharmaceuticalsの株価下落に賭けている度合いを知ることができます。空売りデータは2週間ごとに更新されます。

Amylyx Pharmaceuticals (NASDAQ:AMLX) 株価情報, 空売り情報

Amylyx Pharma

Amylyx Pharmaceuticals Inc is a clinical-stage pharmaceutical company working on developing a novel therapeutic for amyotrophic lateral sclerosis and other neurodegenerative diseases. It has one operating segment which is the business of researching and developing therapeutics for neurodegenerative disorder and endocrine conditions.

Amylyx Pharmaceuticals, Inc. - Common Stock

Amylyx Pharmaceuticals Inc

<a href="https://x.com/TonySage7237/status/1917531832897396829" title="https://x.com/TonySage7237/status/1917531832897396829">https://x.com/TonySage7237/status/1917531832897396829</a>

News

CRML

Tony Sage Executive Chairman of Critical Metals Corp Posts On X "Had a great chat to the Speaker regarding China's monopoly on rare earths and how Tanbreez is the solution."

Stifel analyst Nathan Jones maintains Xylem (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XYL#NYSE">XYL</a>) with a Buy and raises the price target from $140 to $141.

Price Target

Analyst Ratings

Stifel Maintains Buy on Xylem, Raises Price Target to $141

Stifel analyst J. Bruce Chan maintains United Parcel Service (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/UPS#NYSE">UPS</a>) with a Buy and lowers the price target from $145 to $124.

Stifel Maintains Buy on United Parcel Service, Lowers Price Target to $124

Charles d'Haussy, director of the DYDX Foundation, forecasts a Bitcoin (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/btc/usd">BTC</a>) price surge to $150,000 by mid-October 2025, followed by a capital rotation into altcoins, driven by clearer U.S. regulations and <a href="https://www.benzinga.com/markets/equities/25/04/45032435/trump-tariffs-prompt-suspension-of-chinese-factory-operations-and-shift-to-new-markets">settling tariff disputes</a>.
What Happened: In an interview with Benzinga, d'Haussy shared his outlook for the cryptocurrency market, emphasizing the impact of the Trump administration's policies and global economic shifts on decentralized finance and crypto derivatives.
D'Haussy predicted that within the next 100 days, the U.S. will see the passage of the <a href="https://www.benzinga.com/content/44656762/sec-says-certain-stablecoins-qualify-as-non-securities-under-new-guidelines">Genius Act and Stablecoin Act</a>, enabling banks to mint and manage stablecoins, thus boosting market liquidity.
He anticipates these regulatory clarifications will stabilize markets, allowing investors to better navigate the tariff-driven economic landscape.
He further noted that tariff disputes will resolve country by country, providing clarity on economic impacts by late summer. 
This, combined with central banks' responses to weakening domestic economies, will trigger a "printing festival" starting with the U.S. Federal Reserve by September 2025. 
"Come September, there's gonna be a printing festival. So the first one to start the dance of the printing festival will be the central banks of the U.S.," d'Haussy said, predicting increased fiat and stablecoin liquidity that will fuel equity and crypto market rallies.
Bitcoin, as the market's flagship asset, will lead the charge, potentially reaching $150,000 by mid-October, according to d'Haussy. 
He expects institutional investors, viewing Bitcoin as a store of value akin to gold, to then rotate profits into altcoins, starting with Ethereum (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/eth/usd">ETH</a>), which he projects could hit $5,000.
"Bitcoin will pump first because the brand is there. Bitcoin is the father of all of us, is the OG," he remarked, highlighting its market dominance.
Also Read: <a href="https://www.benzinga.com/markets/25/04/45026968/bitcoin-fundamentally-decoupled-from-us-tech-stocks-blackrocks-jay-jacobs-says">Bitcoin Fundamentally Decoupled From US Tech Stocks, BlackRock&#8217;s Jay Jacobs Says</a>
Why It Matters: The rotation into altcoins will favor DeFi projects like DYDX, Aave (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/aave/usd">AAVE</a>), Lido (CRYPTO: LIDO), Uniswap (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/uni/usd">UNI</a>), and Morpho, which d'Haussy believes offer tangible business models and clear paths to profitability.
"The one which have a business are mostly in DeFi… you can look at the business and think, okay, this token is underpriced or overpriced," he explained, contrasting these with speculative projects lacking fundamentals.
DYDX, a decentralized exchange (DEX) focused on crypto derivatives, has processed $1.5 trillion in trading volume since 2018 and $200 billion on its proprietary DYDX chain since migrating from Ethereum two years ago. 
Its unique staking model rewards users with USDC from protocol fees, distinguishing it from inflationary staking systems like Ethereum or Solana (CRYPTO: <a class="ticker" href="https://www.benzinga.com/quote/sol/usd">SOL</a>). 
D'Haussy acknowledged the need for cautious retail engagement, advocating for trust in established brands like DYDX to rebuild confidence. 
He also highlighted DeFi's transparency, noting that platforms like DYDX provide open data accessible to all, including AI trading agents, which are beginning to interact with the platform. 
While optimistic about DeFi's growth, he cautioned that not all altcoins will benefit equally, urging investors to focus on projects with proven business models.
Read Next: 
<ul>
<li><a href="https://www.benzinga.com/markets/25/04/45026851/bitcoin-etfs-see-442m-daily-inflow-as-btc-hovers-around-94-000">Bitcoin ETFs See $442M Daily Inflow As BTC Hovers Around $94,000</a></li>
</ul>
Image: Shutterstock

Coverage of Bitcoin, Etherum, Ripple and all the latest digital currencies.

Cryptocurrency

$AAVE

$BTC

$ETH

$SOL

$UNI

Bitcoin To Hit $150,000 By October, Says DYDX's Charles d'Haussy

Stifel analyst Adam Borg maintains Tenable Holdings (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/TENB#NASDAQ">TENB</a>) with a Hold and lowers the price target from $45 to $30.

TENB

Stifel Maintains Hold on Tenable Holdings, Lowers Price Target to $30

Stifel analyst Chris O'Cull maintains Starbucks (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SBUX#NASDAQ">SBUX</a>) with a Buy and lowers the price target from $103 to $92.

SBUX

Stifel Maintains Buy on Starbucks, Lowers Price Target to $92

Stifel analyst Shlomo Rosenbaum maintains S&amp;P Global (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/SPGI#NYSE">SPGI</a>) with a Buy and lowers the price target from $629 to $603.

SPGI

Stifel Maintains Buy on S&P Global, Lowers Price Target to $603

<a href="https://www.youtube.com/watch?v=B-1xpqn6z2o" title="https://www.youtube.com/watch?v=B-1xpqn6z2o">https://www.youtube.com/watch?v=B-1xpqn6z2o</a>

Management

TSLA

President Trump Tells Elon Musk, "You're Invited To Stay As Long As You Want.. You've Done A Fantastic Job"

Stifel analyst Stephen Gengaro maintains ProPetro Holding (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/PUMP#NYSE">PUMP</a>) with a Buy and lowers the price target from $12 to $11.

PUMP

Stifel Maintains Buy on ProPetro Holding, Lowers Price Target to $11

GameStop (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/GME#NYSE">GME</a>) has outperformed the market over the past 5 years by 68.65% on an annualized basis producing an average annual return of 82.53%. Currently, GameStop has a market capitalization of $12.21 billion. 
Buying $1000 In GME: If an investor had bought $1000 of GME stock 5 years ago, it would be worth $19,927.01 today based on a price of $27.30 for GME at the time of writing.
<h3>GameStop's Performance Over Last 5 Years</h3>
<img src="https://www.benzinga.com/files/images/story/2025/1746031512_0.png" alt="comp_fig" />
Finally -- what's the point of all this? The key insight to take from this article is to note how much of a difference compounded returns can make in your cash growth over a period of time.
This article was generated by Benzinga's automated content engine and reviewed by an editor.

Trading Ideas

If You Invested $1000 In This Stock 5 Years Ago, You Would Have This Much Today

Stifel analyst Matthew Smith maintains Mondelez International (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/MDLZ#NASDAQ">MDLZ</a>) with a Buy and raises the price target from $70 to $73.

MDLZ

Stifel Maintains Buy on Mondelez International, Raises Price Target to $73

Stifel analyst Matthew Smith maintains Kraft Heinz (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/KHC#NASDAQ">KHC</a>) with a Hold and lowers the price target from $31 to $30.

Stifel Maintains Hold on Kraft Heinz, Lowers Price Target to $30

Stifel analyst Simon Yarmak maintains Equity Residential (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EQR#NYSE">EQR</a>) with a Buy and lowers the price target from $82.25 to $80.

Stifel Maintains Buy on Equity Residential, Lowers Price Target to $80

Stifel analyst Shlomo Rosenbaum maintains Ecolab (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/ECL#NYSE">ECL</a>) with a Buy and lowers the price target from $307 to $303.

Stifel Maintains Buy on Ecolab, Lowers Price Target to $303

Stifel analyst Nathan Jones maintains Crane (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/CR#NYSE">CR</a>) with a Hold and raises the price target from $144 to $150.

Stifel Maintains Hold on Crane, Raises Price Target to $150

Stifel analyst Steven Wieczynski maintains Caesars Entertainment (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CZR#NASDAQ">CZR</a>) with a Buy and lowers the price target from $51 to $42.

Stifel Maintains Buy on Caesars Entertainment, Lowers Price Target to $42

Stifel analyst J. Bruce Chan maintains ArcBest (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ARCB#NASDAQ">ARCB</a>) with a Buy and lowers the price target from $102 to $83.

ARCB

Stifel Maintains Buy on ArcBest, Lowers Price Target to $83

Clean Energy Technologies, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/CETY#NASDAQ">CETY</a>) (the "Company" or "CETY").
Dear Shareholders,
As we navigate an ever-changing clean energy landscape shaped by global economic and political dynamics, I want to reaffirm our commitment to you of being both transparent and informative. My goal is to ensure you have a clear understanding of our company's short-term objectives and long-term strategies.
At Clean Energy Technologies, we understand the critical need for adaptability in this fast-evolving market. We are focused on positioning ourselves to capitalize on opportunities, overcome challenges, and drive sustainable growth and profitability while creating value for our shareholders.
Being a NASDAQ-listed clean energy company is both an opportunity and a challenge, especially with limited resources in a capital-intensive industry. But we remain focused on execution, innovation, and building long-term value.
Since our uplisting in 2023, we've gained better access to capital markets but truly haven't been able to take advantage of it for various reasons. We've made strategic moves to tighten operations and focus on areas that align with our strengths and form synergistic strategic partnerships to expand our capabilities across multiple applications in order to scale up.
One major milestone is our Vermont Renewable Gas (VRG) biomass waste to energy project:
<ul>
<li>$12M secured for construction</li>
<li>$20M long-term O&amp;M agreement</li>
<li>CETY serving as technology provider and O&amp;M partner &nbsp;</li>
</ul>
The Vermont Renewable Gas (VRG) project serves as a model for how CETY plans to engage in future clean energy infrastructure—providing engineering, procurement, proprietary technology, and long-term operations and maintenance services. Several similar opportunities are currently in development, each with the potential to add significant value to our backlog through EPC and service agreements.
We have successfully navigated a year-long permitting process for VRG, with all permits we believe are necessary secured except for the final sign-off from the Public Utility Commission. With the other permits secured, we are in the final stages of regulatory review and are preparing to proceed with project execution upon approval.
We're also growing our pipeline in heat to power and geothermal, deploying our proprietary technology into sectors like industrial manufacturing, data centers, and utilities. The $500K Qymera project secured in Q1 2025 is as a result of that. We are currently preparing our shipment to Qymera.
In parallel, we've positioned CETY as a full-scope, eco-friendly energy and microgrid solutions provider by forming strategic partnerships with Metis Power and Exergy. Together, we offer integrated systems that encompass power generation, large-scale heat recovery, energy storage, and advanced energy management. As a result, we currently have multiple data center and large-scale heat-to-power project bids under consideration. These projects are capital-intensive and require financing through private equity or infrastructure funds, which can lead to longer lead times before contracts are finalized.
Due to macroeconomic factors such as declining natural gas prices and reduced industrial demand, we expect lower near-term revenues from our natural gas activities. As a result, CETY HK will defer the commencement of the Shenzhen Gas joint venture until market conditions are more favorable.
Tariffs are expected to affect the cost structure of our heat-to-power products at a time when we are actively focused on reducing production costs. To help mitigate these pressures, we are pursuing international manufacturing partnerships aimed at optimizing efficiency and maintaining our competitiveness in the market.
To support these efforts, we've built a talented, multidisciplinary team across engineering, systems integration, procurement, and technical services—with a focus on seamless project delivery from design to commissioning.
We continue to collaborate with project developers and private equity partners to expand our market reach. In these partnerships, CETY provides the core technology, execution capabilities, and long-term operations and maintenance services, while our partners lead on financing and asset ownership through power purchase agreement (PPA) structures.
Here's our strategy going forward:
<ul>
<li>Deliver turnkey clean energy solutions including technology, EPC, and O&amp;M services.</li>
<li>Expand across multiple applications including power generation, waste to energy, and heat to power solutions.</li>
<li>Strengthen strategic partnerships to offer integrated microgrid and energy systems.</li>
<li>Establish captive partnerships to support developers and project financiers with the technical foundation to scale clean energy infrastructure.</li>
<li>Prioritize markets where we can lead such as industrial manufacturing, data centers, and waste-to-energy, where our proprietary technologies can deliver reliable, scalable, and cost-effective clean energy solutions. &nbsp;</li>
</ul>
We remain committed to executing our strategy and building long-term value. While challenges remain, our recent developments and partnerships reflect meaningful progress toward establishing CETY as a reliable provider of clean energy technologies and solutions.

Contracts

CETY

Clean Energy Technologies CEO Sends Letter To Shareholders; Discusses Vermont Renewable Gas Biomass Waste To Energy Project Including $12M Secured For Construction And $20M Long-Term O&M Agreement

Stifel analyst Matthew Smith maintains Altria Group (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/MO#NYSE">MO</a>) with a Buy and raises the price target from $60 to $63.

Stifel Maintains Buy on Altria Group, Raises Price Target to $63

<a href="https://www.bloomberg.com/news/articles/2025-04-30/china-lifts-sanctions-on-european-lawmakers-amid-trump-tariffs">https://www.bloomberg.com/news/articles/2025-04-30/china-lifts-sanctions-on-european-lawmakers-amid-trump-tariffs</a>

Politics

Economics

General

'China Lifts Sanctions on European Lawmakers Amid Trump Tariffs'- Bloomberg

Press Releases

Amylyx Pharmaceuticals Announces Pricing of Public Offering of Common Stock

Amylyx Pharmaceuticals Announces FDA Has Lifted the Clinical Hold on AMX0114 Phase 1 Clinical Trial for the Treatment of Amyotrophic Lateral Sclerosis

Amylyx Pharmaceuticals to Present at the Oppenheimer 35th Annual Healthcare Life Sciences Conference

Amylyx Pharmaceuticals to Report Fourth Quarter and Full Year 2024 Financial Results on March 4, 2025

Amylyx Pharmaceuticals to Participate in Upcoming March Investor Conferences

Amylyx Pharmaceuticals Reports Fourth Quarter and Full Year 2024 Financial Results

Amylyx Pharmaceuticals to Present at the 24th Annual Needham Virtual Healthcare Conference

Amylyx Pharmaceuticals Announces First Participant Dosed in Phase 1, Multiple Ascending Dose LUMINA Trial of AMX0114 in People Living with Amyotrophic Lateral Sclerosis

Comments

Amylyx Pharmaceuticals

空売り

Amylyx Pharmaceuticals (NASDAQ:AMLX) 株価情報, 空売り情報

こんな人も見ています

ニュース

パートナーシップ

ベンジンガ・グローバル